Transforming market access

Here to make market access easier, faster, and better

Why we do what we do

The pharmaceutical sector is facing seismic challenges. Budgets are being squeezed. Payer expectations are shifting. The only way to stay one step ahead is to adapt.

Access Infinity was founded in 2014 to help pharma companies confront these challenges head-on. We began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies.

Since then, we’ve introduced our market-redefining digital tools, Access Hub, Evidence Hub and NURO to help market access teams work smarter, faster and more efficiently.

Our aim is simple: to streamline decision-making and strategy development across a pharma product’s life cycle.

The journey to faster, more efficient market access decision-making starts here.

Market access experts at your fingertips

Access Infinity’s Consulting Team experts – with a combined 250+ years of experience – have completed over 1500 market access consulting projects in 4 continents.

Meet the leadership team

Shri has over 14 years industry experience, working with firms like Merck and Lundbeck, Access Partnership and Double Helix. Shri has a PhD from the Asian Institute of Technology and an MPhil from the University of Cambridge.

Shrinivas Rao Mukku
Founding Director

Ahmed has developed market access strategies for over 100 products, covering all major geographies. Ahmed holds an MPhil in Bioscience Enterprise from the University of Cambridge and an MSc in Biochemical Engineering.

Ahmed Edathodu
Founding Director

Brett has worked at the highest levels of market access consultancy with a special interest in complex qualitative payer & quantitative pricing research. Brett is a University of Cambridge graduate with a background microbiology, immunology & oncology

Brett Gardiner

Isabel has supported companies develop their Pricing & Market Access strategy for products across all major therapeutic areas and key commercial markets, from Europe and the US to Japan. She has a particular interest in early pipeline products. She is a graduate of ICADE Business School in Madrid.

Isabel Rubio

Keshav brings over 20 years of business leadership success, advising clients on their IT and Digital strategy and leading global cross-functional teams. Keshav is an Electronics & Telecommunications Engineer with an MBA in Marketing.

Keshav Nagaraja
Managing Director

A consultant to the biopharmaceutical industry for over 20 years, Nick has trained many executives on global pricing and market access. Nick has a PhD in Medicine and Pharmacy from the University of Manchester.

Nick Proctor

Steve has spent the last 12+ years partnering with top-20 biopharma companies to unlock the interdependencies between value, evidence, access, and pricing for numerous major brands globally. Steve has an MBA from Durham University Business School.

Steven Fountain

Meet the team

0 +
Years combined experience
Global Offices
Industry recognition

Our work hasn’t gone unnoticed. We’re rapidly gaining a strong reputation across the industry, including several internationally recognised awards.

Stevie Award Small Company of the Year 2021

Top 5 Pharma Tech Company in UK 2021

We work with the best